Progress in the Management of Malignant Pleural Mesothelioma in 2017-Reference-Cited by-同舟云学术

Progress in the Management of Malignant Pleural Mesothelioma in 2017

Published:2018-05 Issue:5 Volume:13 Page:606-623
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

McCambridge Amanda J.,Napolitano Andrea,Mansfield Aaron S.,Fennell Dean A.,Sekido Yoshitaka,Nowak Anna K.,Reungwetwattana Thanyanan,Mao Weimin,Pass Harvey I.,Carbone Michele,Yang Haining,Peikert Tobias

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference204 articles.

1. Malignant mesothelioma: facts, myths, and hypotheses;Carbone;J Cell Physiol,2012

2. Mesothelioma from asbestos exposures: epidemiologic patterns and impact in the United States;Lemen;J Toxicol Envir Health B Crit Rev,2016

3. Occupational exposure to asbestos: population at risk and projected mortality–1980-2030;Nicholson;Am J Ind Med,1982

4. Malignant mesothelioma mortality—United States, 1999-2015;Mazurek;MMWR Morb Mortal Wkly Rep,2017

5. Asbestos is not just asbestos: an unrecognised health hazard;Baumann;Lancet Oncol,2013

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Germline BARD1 variants predispose to mesothelioma by impairing DNA repair and calcium signaling;Proceedings of the National Academy of Sciences;2024-07-11

2. Pharmacological inhibition of CDK4/6 impairs diffuse pleural mesothelioma 3D spheroid growth and reduces viability of cisplatin-resistant cells;Frontiers in Oncology;2024-07-01

3. Therapeutic Strategies to Improve the Treatment of Pleural Mesothelioma;Current Medicinal Chemistry;2024-04-16

4. Combination of EZH2 and ATM inhibition in BAP1-deficient mesothelioma;British Journal of Cancer;2024-03-22

5. Pin penetration depths in the neurocranium using a three-pin head fixation device;Scientific Reports;2024-02-27